| Latest Parexel News Headlines |
| Date | Time | Source | |
| 10/07/2008 | 10:51AM | PRNUS | PAREXEL Announces Date of First Quarter Fiscal Year 2009 Earnings Release and Conference Call
BOSTON, Oct. 7 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) will release First Quarter Fiscal Year 2009 financial results on Monday, October 27, 2008 after the close of the stock market. The announcement will be available on PAREXEL's website at http://www.parexel.com/ and on the PR Newswire... More...>> |
| 10/06/2008 | 6:00AM | PRNUS | PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference
BOSTON, Oct. 6 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) announced today it will be presenting at the William Blair Small-Cap Growth Stock Conference in New York, NY. James Winschel, Senior Vice President and Chief Financial Officer will be making a formal presentation on PAREXEL at... More...>> |
| 09/23/2008 | 6:00AM | PRNUS | PAREXEL Expands Early Phase Drug Development Capabilities with Dedicated Proof of Concept Solutions
BOSTON, Sept. 23 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, today announced that the Company has expanded its early phase drug development capabilities to provide biopharmaceutical companies with dedicated support for Proof of Concept... More...>> |
| 09/08/2008 | 4:01PM | PRNUS | PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors
BOSTON, Sept. 8 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, today updated its forward-looking financial guidance for the first quarter of Fiscal Year 2009 (ending September 30, 2008) and for the full Fiscal Year, in conjunction... More...>> |
| 09/02/2008 | 6:00AM | PRNUS | PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
BOSTON, Sept. 2 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) announced today it will be presenting at the Thomas Weisel Partners Healthcare Conference in Boston, MA. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a formal presentation on PAREXEL at 3:50 p.m. EDT... More...>> |
| 08/25/2008 | 6:00AM | PRNUS | PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
BOSTON, Aug. 25 /PRNewswire-FirstCall/ -- New data from PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, reveal that U.S. marketing applications for new molecular entities (NMEs) surged 33 percent in 2007. While NME approvals reached a many-year low of 16 in... More...>> |
| 08/14/2008 | 6:30AM | PRNUS | PAREXEL Closes the Acquisition of ClinPhone
Combined Capabilities Create the Industry's Largest eClinical Technology Offering
BOSTON, Aug. 14 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, today announced the successful closing of the acquisition of ClinPhone plc, a leading... More...>> |
| 08/06/2008 | 4:03PM | PRNUS | PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
- Record quarterly and Fiscal Year service revenue grows approximately 33% and 30%, respectively
BOSTON, Aug. 6 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) today announced its financial results for the fourth quarter and Fiscal Year ended June 30, 2008.
For the three months ended June... More...>> |
| 07/28/2008 | 6:00AM | PRNUS | Perceptive Informatics Appoints Leading Imaging Expert Dr. Kenneth G. Faulkner to Vice President of Medical Imaging
BOSTON, July 28 /PRNewswire-FirstCall/ -- Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, announced today that it has appointed Kenneth G. Faulkner, Ph.D., to the position of Vice President of Medical Imaging... More...>> |
| 07/22/2008 | 7:15AM | PRNUS | ClinPhone Shareholders Approve Acquisition by PAREXEL
BOSTON, July 22 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization ("PAREXEL" or the "Company"), today provided an update with regard to the previously announced proposal whereby an indirect wholly owned subsidiary of PAREXEL will acquire... More...>> |
| 07/16/2008 | 9:00AM | PRNUS | PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
BOSTON, July 16 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, announced today that it has promoted Mark A. Goldberg, M.D., to Chief Operating Officer (COO). Dr. Goldberg previously served as President of Clinical Research Services... More...>> |
| 07/08/2008 | 6:00AM | PRNUS | PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
BOSTON, July 8 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) will release Fourth Quarter and Fiscal Year 2008 financial results on Wednesday, August 6, 2008 after the close of the stock market. The announcement will be available on PAREXEL's website at http://www.parexel.com/ and on the... More...>> |
| 06/24/2008 | 4:02PM | PRNUS | PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
BOSTON, June 24 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) announced today that it will discuss forward-looking earnings expectations for the fourth quarter of Fiscal Year 2008 (ending June 30, 2008), for Fiscal Year 2008 in its entirety, and for Fiscal Year 2009 at its Investor Day being... More...>> |
| 06/23/2008 | 6:00AM | PRNUS | PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
BOSTON, June 23 /PRNewswire-FirstCall/ -- According to new data from PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, the number of new industry-sponsored clinical trial initiations, or starts, surged another 12 percent to a record high in 2007. PAREXEL's analysis... More...>> |
| 06/19/2008 | 12:38PM | PRNUS | PAREXEL Expands Global Clinical Logistics Capabilities
Companies can avoid developing their own internal systems and managing multiple vendors by taking advantage of PAREXEL's global team of experts and distribution infrastructure
BOSTON, June 19 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization... More...>> |
| 06/18/2008 | 9:15AM | PRNUS | Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
BOSTON, June 18 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day on Wednesday, June 25, 2008, from 8:30 a.m. to 12:30 p.m. (EDT).
All interested parties are invited... More...>> |
| 06/17/2008 | 6:00AM | PRNUS | PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
BOSTON, June 17 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services provider, today announced that it is expanding its clinical pharmacology capabilities in the Central Nervous System (CNS) therapeutic area. PAREXEL is enhancing existing services in... More...>> |
| 06/16/2008 | 6:00AM | PRNUS | PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
BOSTON, June 16 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, will present in more than 20 sessions at the Drug Information Association (DIA) 44th Annual Meeting. The meeting will be held June 22 -- 26, 2008 at the Boston... More...>> |
| 06/13/2008 | 6:53AM | PRNUS | PAREXEL Reaches Agreement To Acquire ClinPhone
Combined Capabilities to Create One of the Industry's Largest eClinical Technology Offerings
BOSTON, June 13 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, today announced that the Boards of PAREXEL International and ClinPhone plc... More...>> |
| 06/05/2008 | 10:18AM | PRNUS | PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
BOSTON, June 5 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (NASDAQ:PRXL) announced today it will be presenting at the Goldman Sachs 29th Annual Global Healthcare Conference at The Ritz Carlton - Laguna Niguel in Dana Point, California. James Winschel, Senior Vice President and Chief Financial Officer... More...>> |